Rebbeck's results show that the proportion of cancer-affected individuals carrying mutated BRCA1 with BC was 72.9%, with OC 18.7% and with a personal history of breast and ovarian cancer was 8.4%. This evidence concerns the gene BRCA1 and cancer.